about
Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with theβ-Blockers and All-Cause Mortality in Adults with Episodes of Acute Bronchitis: An Observational StudyUse of expert panels to define the reference standard in diagnostic research: a systematic review of published methods and reportingStrategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trialPrevalence of unrecognized heart failure in older persons with shortness of breath on exertion.2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).Heart-type Fatty acid-binding protein in Acute Myocardial infarction Evaluation (FAME): background and design of a diagnostic study in primary care.Early recognition of heart failure in patients with diabetes type 2 in primary care. A prospective diagnostic efficiency study. (UHFO-DM2).Resting heart rate is a risk factor for mortality in chronic obstructive pulmonary disease, but not for exacerbations or pneumoniaRecognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study.Triage of frail elderly with reduced exercise tolerance in primary care (TREE). A clustered randomized diagnostic study.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribMeasurement of ECG abnormalities and cardiovascular risk classification: a cohort study of primary care patients in the Netherlands.Serum biomarkers for the early diagnosis of TIA: The MIND-TIA study protocol.Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease.COPD in patients with stable heart failure in the primary care setting."GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study".Rationale, design and baseline results of the Treatment Optimisation in Primary care of Heart failure in the Utrecht region (TOPHU) study: a cluster randomised controlled trial.Heart failure and chronic obstructive pulmonary disease: An ignored combination?Extended prediction rule to optimise early detection of heart failure in older persons with non-acute shortness of breath: a cross-sectional study.Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.B-type natriuretic peptide assays for detecting heart failure in the elderly: same value as those in the younger?Do general practitioners follow treatment recommendations from guidelines in their decisions on heart failure management? A cross-sectional studyDevelopment and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease.Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead electrocardiogram device during influenza vaccination.Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology.Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction: a systematic review and meta-analysis.β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.Primary care patients with heart failure in the last year of their life.Highlights of the 2011 scientific sessions of the Congress of the Heart Failure Association of the European Society of Cardiology.Smoking cessation strategies in patients with COPD.Point-of-care tests in suspected acute myocardial infarction: a systematic review.Prevalence and underlying causes of dyspnoea in older people: a systematic review.Association of varicosities and concomitant deep venous thrombosis in patients with superficial venous thrombosis, a systematic review.Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence.Chronic obstructive pulmonary disease in heart failure: accurate diagnosis and treatment.Effectiveness of an interactive platform, and the ESC/HFA heartfailurematters.org website in patients with heart failure: design of the multicentre randomized e-Vita heart failure trial.
P50
Q28194541-2336DD7C-6769-4AE4-A64D-F996EAC78FB3Q28267062-5BF3A1AD-AAA5-4128-AD33-DBA8434F6E0FQ28533991-C6DF8005-6E64-4DBA-A348-7E874F0A3F93Q28674120-899222D3-43E1-4818-8AF0-D1DC02DC841FQ30486604-CFB99A7F-3B15-4057-B98C-6D1C59B956E5Q30486992-090D879F-FB58-4A2E-9B84-ACE1AEF6E7ABQ33164685-72B15746-669B-4670-B3A6-12115EBFC3CDQ33328298-8AA8E6AE-0500-4383-90C1-A5978DAF226FQ33520099-0FE93436-08AC-4C1C-AF38-AD5A45701DEBQ34089856-026C043D-D4C7-4469-BF2E-962AC1676CCAQ34203867-BFC64600-D820-4FE7-B2B2-F4245523287CQ34284279-F8B80B29-1E5B-4F76-B029-060FAA196C44Q34527664-E00D2F5A-3A89-4262-8D1A-5E3DF71520FAQ34640762-62065B8D-D067-4AC5-B767-33AE0BE94D38Q34677347-96FEB5C9-F67C-4048-A1D0-234E3A373FA7Q34769110-8FCF6391-44BC-4601-B74D-D5C57883C7A3Q35717391-C8D6B32D-7D32-4A50-BCBA-ADD021223876Q35728312-819365EC-A587-4CBC-A60A-332844958D94Q35822051-7D187C52-FCAA-4BC8-A461-8637DFE4D317Q35822472-5B9AAEE9-03B5-4F73-A3DF-76181EE1B35BQ36131080-A9A4AB48-F1B3-4E9A-A1ED-452B24621FDFQ36418960-57F829C9-9A99-4517-A1F5-89F6FFD6F2AAQ36602987-A9D57A78-BCC1-471F-8379-4AD48810AEF3Q36715249-C48437FD-4747-4623-B353-E8792400951BQ36982816-BEAEB2CE-7800-4C2E-966E-6CB5254A4BC6Q37190371-C5CE7FAB-44B6-461A-BDCB-57EEBDF280A1Q37232113-7E30EF6B-0E3D-45D2-A0C7-CC7C7E528B60Q37353367-1C7884C9-6B66-41A3-98BF-47343C01F624Q37455607-22A43E8E-186F-4E10-ADEC-94E59E109321Q37810699-E55DFED4-1FA9-43A0-B362-BFC26497E1A3Q37822723-63F5C7B9-FFE7-45CC-AABC-58AE35F0ADEDQ37910639-9C7D73DE-4A5C-4CF9-ADE4-81CE9981CF0CQ37952249-5CB29403-7848-452F-80DA-5F48E794980CQ38039404-66006D3E-9CF1-4E16-8F26-6CDFC059F30EQ38133905-F3E30F9B-06A0-44CD-ABBF-2CF61C4F3F39Q38182811-79BEF202-8586-46DB-8A0F-E6FB6F0946BBQ38218551-FAD8879A-68F2-4F8A-8F13-8416FF858FB7Q38224810-C55AA40E-9CF5-4168-9D29-773051703A1BQ38262835-C430AED2-603D-4496-8523-B868ECCBFA53Q38402757-A0234354-BDEB-49E4-9A6C-DC9807D52137
P50
name
Frans H Rutten
@ast
Frans H Rutten
@en
Frans H Rutten
@nl
type
label
Frans H Rutten
@ast
Frans H Rutten
@en
Frans H Rutten
@nl
prefLabel
Frans H Rutten
@ast
Frans H Rutten
@en
Frans H Rutten
@nl